Article
Prediagnostic plasma vascular endothelial growth factor levels and risk of prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Jun 2005
Li Haojie, Kantoff Philip W, Ma Jing, Stampfer Meir J, George Daniel J
Abstract excerpt
Vascular endothelial growth factor (VEGF) plays important roles in endothelial cell proliferation, vascular permeability, and angiogenesis that may be critical to prostatic carcinogenesis and progression. Plasma VEGF levels were significantly greater in patients with metastatic prostate cancer compared with those with localized disease or healthy controls, and plasma VEGF level at prostate cancer diagnosis was an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
